To further provide unequivocal evidence for this hypothesis, efficacy studies using Ido1-expressing and Ido1-knockout 4T1 breast cancer models showed that the IDO1-NP potently suppressed tumor growth with high Ido1 expression. Here, IDO1 is linked to neoplasm.